Siemens appoints Vasi Philomin to lead expansion of industrial AI innovation

Anthony Casciano President and CEO Siemens Financial Services
Anthony Casciano President and CEO - Siemens Financial Services
0Comments

Siemens has announced the appointment of Vasi Philomin as a leader in its AI-powered initiatives, aiming to expand its offerings which currently include 35 applications such as the Industrial Copilot. Under Philomin’s guidance, Siemens plans to develop an industrial foundational model that ensures industrial-grade AI for customers, focusing on safety, security, reliability, and trustworthiness. Philomin will report directly to Peter Koerte, a member of the Managing Board and Chief Technology Officer at Siemens AG.

Philomin transitions from Amazon where he was Vice President of Generative AI at Amazon Web Services (AWS). At Amazon, he played a key role in developing Amazon Bedrock and managing foundation models. His background includes advanced machine learning and enterprise-scale AI deployment.

“We are delighted to welcome Vasi Philomin to Siemens. Vasi brings a rare combination of deep technical expertise, strategic vision, and strong record in execution,” stated Peter Koerte. “His outstanding expertise in AI and proven leadership in building transformative technologies will be instrumental in scaling our data and AI capabilities.”

Vasi Philomin expressed enthusiasm about his new position: “I’m thrilled to join Siemens at a time when the boundaries between the physical and digital worlds are being redrawn by AI. The next great frontier for artificial intelligence is the physical world – powering machines, factories, and infrastructure that sense, reason, and act.”

Philomin has over two decades of experience in technology leadership roles. Prior to his tenure at Amazon, he held senior positions at Philips leading global innovation initiatives. He holds a PhD in Computer Science with emphasis on machine learning and computer vision from the University of Maryland.



Related

Paul Hudson Chief Executive Officer Sanofi SA

Acoziborole receives key EU panel backing as single-dose treatment for sleeping sickness

Acoziborole Winthrop, a new oral treatment for sleeping sickness developed by the Drugs for Neglected Diseases initiative (DNDi) and Sanofi, has received a positive opinion from the European Medicines Agency’s Committee for Medicinal Products for…

Martin Lundstedt President and CEO at Volvo Group North America LLC Volvo Group North America LLC

Volvo announces updated share and vote count after series conversion

The number of votes in AB Volvo has changed following the conversion of 2,000,619 Series A shares into an equal number of Series B shares.

Paul Hudson Chief Executive Officer Sanofi SA

Sanofi and Regeneron’s Dupixent recommended for EU approval in young children with chronic urticaria

Sanofi and Regeneron have announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending approval of Dupixent (dupilumab) for children aged two to 11 years with…

Trending

The Weekly Newsletter

Sign-up for the Weekly Newsletter from EU Business Daily.